Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC2 | O75106 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 10/20 | 0.39 |
| ▸ | CA2 | P00918 | 10/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 2/20 | 0.35 |
| ▸ | MMP1 | P03956 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP3 | P08254 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 4/20 | 0.34 |
| ▸ | CA9 | Q16790 | 4/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | MMP7 | P09237 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17420149 | 0.86 | CA1 (0.53) | AOC2CA1CA2RORCTSHR | |
| SCHEMBL6310046 | 0.85 | CA1 (0.49) | CA1CA2RECQLMMP1MMP2 | |
| SCHEMBL5855875 | 0.82 | CA1 (0.46) | CA1CA2CA12CA9CA7 | |
| SCHEMBL3104520 | 0.81 | CA1 (0.45) | CA1CA2RECQLMMP3MMP13 | |
| SCHEMBL454991 | 0.81 | HSD11B1 (0.48) | CA1CA2KDM4EMMP1MMP2 | |
| SCHEMBL3126070 | 0.80 | CA1 (0.44) | CA1CA2RECQLMMP3MMP13 | |
| SCHEMBL3130573 | 0.80 | CA1 (0.44) | CA1CA2RECQLMMP3MMP13 | |
| SCHEMBL3774049 | 0.80 | CA1 (0.37) | CA1CA2MMP1MMP2MMP3 | |
| SCHEMBL503836 | 0.79 | HSD11B1 (0.47) | CA1CA2KDM4EMMP1MMP2 | |
| SCHEMBL5113508 | 0.79 | MEN1 (0.35) | CA1CA2KDM4EMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932797-B2 | Photoacid generators | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-20120141939-A1 | PHOTOACID GENERATORS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2012-06-07 | — | — | US | disclosed |
| EP-2458440-A1 | Photoacid generators | Rohm and Haas Electronic Materials LLC (US) | 2012-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120141939-A1 | PHOTOACID GENERATORS | F10, GNG2, H1-0 | AOC2 1575/4885CA1 527/4885CA2 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.